Premium
Savara Inc (SVRA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Mr. David L. LowranceChief Financial & Administrative Officer and Secretary | -116,76k | 360,15k | Derivative Exercise and Sale | 1,11 - 5,04 | 436,03k | - |
| 2026-03-18 | Mr. David L. LowranceChief Financial & Administrative Officer and Secretary | 249,99k | 360,13k | Derivative Exercise and Retained Stock | 1,11 - 4,45 | 436,03k | 134,37% |
| 2026-02-16 | Dr. Joseph S. McCrackenLead Independent Director | 1,81k | 3,18k | Derivative Exercise and Retained Stock | 1,76 | 262,64k | 0,69% |
| 2025-12-19 | Mr. David A. RamsayIndependent Director | -20,00k | 121,22k | Vente | 6,06 | 2,49M | -0,80% |
| 2025-12-14 | Mr. David L. LowranceChief Financial & Administrative Officer and Secretary | -62,96k | 435,68k | Sale to Issuer | 6,92 | 186,05k | -25,28% |
| 2025-12-16 | Mr. David L. LowranceChief Financial & Administrative Officer and Secretary | -32,00k | 0,00 | Other Disposition | - | 186,05k | -14,68% |
| 2025-12-14 | Mr. Matthew PaulsChairman & CEO | -195,71k | 1,35M | Sale to Issuer | 6,92 | 788,05k | -19,89% |
| 2025-12-16 | Mr. Matthew PaulsChairman & CEO | -129,00k | 0,00 | Other Disposition | - | 788,05k | -14,07% |
| 2025-12-14 | Mr. Robert Matthew LutzCOO | -67,76k | 468,90k | Sale to Issuer | 6,92 | 193,98k | -25,89% |
| 2025-12-14 | Ms. Kate McCabeChief Legal Officer | -39,35k | 272,30k | Sale to Issuer | 6,92 | 519,23k | -7,04% |
| 2025-12-14 | Ms. Anne EricksonChief Business & Corporate Affairs Officer | -62,96k | 435,68k | Sale to Issuer | 6,92 | 271,71k | -18,81% |
| 2025-12-10 | Mr. Matthew PaulsChairman & CEO | -23,63k | 0,00 | Other Disposition | - | 662,75k | -3,44% |
| 2025-12-04 | Dr. Yasmine WasfiChief Medical Officer | -21,99k | 140,09k | Sale to Issuer | 6,37 | 58,01k | -27,49% |
| 2025-12-02 | Mr. Nevan Charles ElamIndependent Director | 4,39k | 6,41k | Derivative Exercise and Retained Stock | 1,46 | 26,89k | 19,50% |
| 2025-12-02 | Mr. Nevan Charles ElamIndependent Director | -1,47k | 6,41k | Derivative Exercise and Sale | 1,46 - 5,81 | 26,89k | - |
| 2025-11-14 | Mr. Richard J. HawkinsIndependent Director | 5,86k | 8,56k | Derivative Exercise and Retained Stock | 1,46 | 81,33k | 7,77% |
| 2025-06-20 | Mr. Richard J. HawkinsIndependent Director | 48,23k | 98,57k | Achat | 2,04 | 75,47k | 177,03% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
